Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Passiflora Curarina is a herbal medicinal product developed and marketed by Harras Pharma, a German pharmaceutical company. The product contains a highly concentrated fluid extract of passionflower (*Passiflora incarnata*). It is primarily indicated for the treatment of nervous restlessness and symptoms of nervous stress. A specific variant, Passiflora night Curarina, is used as a traditional herbal medicine to improve well-being during stressful periods and to promote sleep. These products are 100% plant-based, contain pure passionflower extract without additives, and are available exclusively in pharmacies in Germany. Harras Pharma combines traditional medicinal plant knowledge with modern pharmaceutical research to produce these highly concentrated extracts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Passiflora Curarina.